Verastem VSTM
NASDAQ VSTM
$8.15 +0.17 (+2.13%)
As of: Sep 4, 2026 · 3:13 PM EDT

Verastem (VSTM) EBITDA Margin (2018 - 2026)

Verastem (VSTM) posted quarterly EBITDA Margin of 240.46% for Q1 2026, down 1.66% quarter-over-quarter from 236.53% in Q4 2025.

Analysis

Verastem (VSTM) EBITDA Margin (2018 - 2026) Analysis & Trends

Verastem's EBITDA Margin history runs 8 years deep, the most recent figure standing at 240.46% for Q1 2026.

  • In Q1 2026, EBITDA Margin changed N/A year-over-year to 240.46%; the TTM figure through Mar 2026 stood at 344.56% (changed N/A YoY), while the FY2025 annual figure was 550.33%, up 59923.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 240.46%, down from 236.53% in the prior quarter.
  • The five-year high for EBITDA Margin was 182.77% in Q2 2024, with the low at 2047.92% in Q2 2025.
  • The 4-year median for EBITDA Margin is 301.32% (2025), against an average of 620.66%.
  • The sharpest annual moves came in 2022 and 2025: EBITDA Margin surged 74830 bps in 2022, then tumbled 186515 bps in 2025.
  • Verastem's EBITDA Margin stood at 654.08% in 2022, then soared by 72 bps to 182.77% in 2024, then fell by 29 bps to 236.53% in 2025, then dropped by 2 bps to 240.46% in 2026.
  • Business Quant data shows VSTM's EBITDA Margin at 240.46% in Q1 2026, 236.53% in Q4 2025, and 362.17% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 30.15%
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 32.54%
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -562.07%
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 19.06%
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 17.93%
8 Royalty Pharma 28.43 Bn 27.59 Bn - 19.75%
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.36%
10 Verastem 815.95 Mn 679.59 Mn 36.32 Mn -81.62%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -81.62%
Mar 31, 2026 -240.46%
Dec 31, 2025 -236.42%
Sep 30, 2025 -362.15%
Jun 30, 2025 -2,047.92%
Jun 30, 2024 -182.72%
Mar 31, 2022 -654.08%
Dec 31, 2021 -3,029.54%
Sep 30, 2021 -742,300.00%
Jun 30, 2021 -3,188.80%
Mar 31, 2021 -1,402.39%
Dec 31, 2020 -3,311.07%
Sep 30, 2020 19.09%
Jun 30, 2020 -493.71%
Mar 31, 2020 -521.34%
Dec 31, 2019 -920.40%
Sep 30, 2019 -289.01%
Jun 30, 2019 -1,220.57%
Mar 31, 2019 -2,074.81%
Dec 31, 2018 -2,831.32%